Detalles de la búsqueda
1.
Degludec is effective and safe in real-life treatment for patients with type 2 diabetes mellitus and chronic kidney disease stage 3B.
Int J Clin Pract
; 72(6): e13098, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29924466
2.
Results of semaglutide in patients older than 70 years, a real-world study of efficacy and safety.
Minerva Endocrinol (Torino)
; 2023 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37337740
3.
Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression-real-world clinical practice.
Clin Kidney J
; 15(8): 1593-1600, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35892023
4.
Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain.
Front Endocrinol (Lausanne)
; 13: 995646, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36187123
5.
Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice.
Front Endocrinol (Lausanne)
; 13: 851035, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35813629
6.
Insulin degludec allows for better glycaemic control with a lower risk of hypoglycaemia in patients with chronic kidney disease and type 2 diabetes.
Diabetes Res Clin Pract
; 162: 108094, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32113852
Resultados
1 -
6
de 6
1
Próxima >
>>